Annual Cash & Cash Equivalents
$1.73 M
-$2.60 M-60.05%
December 31, 2023
Summary
- As of February 7, 2025, NURO annual cash & cash equivalents is $1.73 million, with the most recent change of -$2.60 million (-60.05%) on December 31, 2023.
- During the last 3 years, NURO annual cash & cash equivalents has fallen by -$3.49 million (-66.86%).
- NURO annual cash & cash equivalents is now -92.45% below its all-time high of $22.94 million, reached on December 31, 2009.
Performance
NURO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$921.50 K
-$685.50 K-42.66%
September 30, 2024
Summary
- As of February 7, 2025, NURO quarterly cash and cash equivalents is $921.50 thousand, with the most recent change of -$685.50 thousand (-42.66%) on September 30, 2024.
- Over the past year, NURO quarterly cash and cash equivalents has dropped by -$338.40 thousand (-26.86%).
- NURO quarterly cash and cash equivalents is now -96.99% below its all-time high of $30.64 million, reached on September 30, 2004.
Performance
NURO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
NURO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -60.0% | -26.9% |
| 3 y3 years | -66.9% | -96.0% |
| 5 y5 years | -74.5% | -82.4% |
NURO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.3% | at low | -96.1% | at low |
| 5 y | 5-year | -92.3% | at low | -96.1% | at low |
| alltime | all time | -92.5% | +6.7% | -97.0% | at low |
NeuroMetrix Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $921.50 K(-42.7%) |
| Jun 2024 | - | $1.61 M(+27.5%) |
| Mar 2024 | - | $1.26 M(-27.3%) |
| Dec 2023 | $1.73 M(-60.0%) | $1.73 M(+18.6%) |
| Sep 2023 | - | $1.46 M(-21.6%) |
| Jun 2023 | - | $1.86 M(-21.6%) |
| Mar 2023 | - | $2.38 M(-45.2%) |
| Dec 2022 | $4.33 M(-80.8%) | $4.33 M(+144.6%) |
| Sep 2022 | - | $1.77 M(-70.5%) |
| Jun 2022 | - | $6.00 M(-74.7%) |
| Mar 2022 | - | $23.77 M(+5.3%) |
| Dec 2021 | $22.57 M(+331.9%) | $22.57 M(-2.8%) |
| Sep 2021 | - | $23.21 M(+177.5%) |
| Jun 2021 | - | $8.36 M(+62.6%) |
| Mar 2021 | - | $5.15 M(-1.5%) |
| Dec 2020 | $5.23 M(+67.2%) | $5.23 M(+6.0%) |
| Sep 2020 | - | $4.93 M(-9.3%) |
| Jun 2020 | - | $5.43 M(+93.0%) |
| Mar 2020 | - | $2.82 M(-9.9%) |
| Dec 2019 | $3.13 M(-53.9%) | $3.13 M(-1.9%) |
| Sep 2019 | - | $3.19 M(-35.7%) |
| Jun 2019 | - | $4.96 M(-31.1%) |
| Mar 2019 | - | $7.20 M(+6.2%) |
| Dec 2018 | $6.78 M(+67.7%) | $6.78 M(-10.0%) |
| Sep 2018 | - | $7.53 M(+5.9%) |
| Jun 2018 | - | $7.11 M(+16.6%) |
| Mar 2018 | - | $6.10 M(+50.8%) |
| Dec 2017 | $4.04 M(+2.4%) | $4.04 M(+1.9%) |
| Sep 2017 | - | $3.97 M(+9.9%) |
| Jun 2017 | - | $3.61 M(-47.6%) |
| Mar 2017 | - | $6.90 M(+74.7%) |
| Dec 2016 | $3.95 M(-68.3%) | $3.95 M(-47.8%) |
| Sep 2016 | - | $7.57 M(-33.2%) |
| Jun 2016 | - | $11.33 M(+29.6%) |
| Mar 2016 | - | $8.74 M(-29.9%) |
| Dec 2015 | $12.46 M(+35.1%) | $12.46 M(+36.7%) |
| Sep 2015 | - | $9.12 M(-27.9%) |
| Jun 2015 | - | $12.64 M(+97.4%) |
| Mar 2015 | - | $6.40 M(-30.6%) |
| Dec 2014 | $9.22 M | $9.22 M(-21.1%) |
| Sep 2014 | - | $11.69 M(-14.7%) |
| Jun 2014 | - | $13.69 M(+80.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $7.58 M(-17.5%) |
| Dec 2013 | $9.20 M(+5.7%) | $9.20 M(+17.4%) |
| Sep 2013 | - | $7.84 M(-18.3%) |
| Jun 2013 | - | $9.59 M(+39.2%) |
| Mar 2013 | - | $6.89 M(-20.8%) |
| Dec 2012 | $8.70 M(-15.5%) | $8.70 M(-20.4%) |
| Sep 2012 | - | $10.93 M(-18.0%) |
| Jun 2012 | - | $13.32 M(-12.4%) |
| Mar 2012 | - | $15.21 M(+47.8%) |
| Dec 2011 | $10.29 M(-39.4%) | $10.29 M(-12.2%) |
| Sep 2011 | - | $11.71 M(-14.0%) |
| Jun 2011 | - | $13.62 M(-9.8%) |
| Mar 2011 | - | $15.10 M(-11.1%) |
| Dec 2010 | $16.99 M(-25.9%) | $16.99 M(-10.2%) |
| Sep 2010 | - | $18.92 M(-0.8%) |
| Jun 2010 | - | $19.08 M(-8.2%) |
| Mar 2010 | - | $20.79 M(-9.3%) |
| Dec 2009 | $22.94 M(+86.4%) | $22.94 M(+4.1%) |
| Sep 2009 | - | $22.04 M(+303.2%) |
| Jun 2009 | - | $5.47 M(-7.7%) |
| Mar 2009 | - | $5.92 M(-51.9%) |
| Dec 2008 | $12.30 M(+73.3%) | $12.30 M(-43.0%) |
| Sep 2008 | - | $21.59 M(+59.8%) |
| Jun 2008 | - | $13.51 M(+24.2%) |
| Mar 2008 | - | $10.88 M(+53.4%) |
| Dec 2007 | $7.10 M(-10.3%) | $7.10 M(+5.9%) |
| Sep 2007 | - | $6.70 M(+40.2%) |
| Jun 2007 | - | $4.78 M(-29.9%) |
| Mar 2007 | - | $6.82 M(-13.8%) |
| Dec 2006 | $7.91 M(-3.2%) | $7.91 M(+20.4%) |
| Sep 2006 | - | $6.57 M(+27.2%) |
| Jun 2006 | - | $5.16 M(-4.3%) |
| Mar 2006 | - | $5.40 M(-34.0%) |
| Dec 2005 | $8.17 M(+322.0%) | $8.17 M(+147.3%) |
| Sep 2005 | - | $3.30 M(+19.3%) |
| Jun 2005 | - | $2.77 M(+13.5%) |
| Mar 2005 | - | $2.44 M(+25.9%) |
| Dec 2004 | $1.94 M(+19.3%) | $1.94 M(-93.7%) |
| Sep 2004 | - | $30.64 M(+197.5%) |
| Jun 2004 | - | $10.30 M(-5.5%) |
| Mar 2004 | - | $10.90 M(+571.8%) |
| Dec 2003 | $1.62 M(-39.9%) | $1.62 M |
| Dec 2002 | $2.70 M | - |
FAQ
- What is NeuroMetrix annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for NeuroMetrix?
- What is NeuroMetrix annual cash & cash equivalents year-on-year change?
- What is NeuroMetrix quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for NeuroMetrix?
- What is NeuroMetrix quarterly cash and cash equivalents year-on-year change?
What is NeuroMetrix annual cash & cash equivalents?
The current annual cash & cash equivalents of NURO is $1.73 M
What is the all time high annual cash & cash equivalents for NeuroMetrix?
NeuroMetrix all-time high annual cash & cash equivalents is $22.94 M
What is NeuroMetrix annual cash & cash equivalents year-on-year change?
Over the past year, NURO annual cash & cash equivalents has changed by -$2.60 M (-60.05%)
What is NeuroMetrix quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of NURO is $921.50 K
What is the all time high quarterly cash and cash equivalents for NeuroMetrix?
NeuroMetrix all-time high quarterly cash and cash equivalents is $30.64 M
What is NeuroMetrix quarterly cash and cash equivalents year-on-year change?
Over the past year, NURO quarterly cash and cash equivalents has changed by -$338.40 K (-26.86%)